Follicular Lymphoma in Chile in the Adult Public Cancer Program: The Impact of Chemoimmunotherapy.
María Elena CabreraCamila PeñaValeska VegaHernán RojasAlvaro PizarroChristine RojasSusana CalderonJacqueline OlivaCecilia HalesBernardita RojasMarvila IntriagoMarisa CapurroM Luisa GonzalezJorge J CastilloPublished in: Cancer reports (Hoboken, N.J.) (2024)
Our study shows a female predominance in patients with FL in Chile and confirms superior response and survival outcomes with adding rituximab to chemotherapy. Our study also confirms a poor OS in patients who experience POD24.